Voyageur Pharmaceuticals Ltd.
VM.V
TSX
| 11/30/2024 | 08/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 26.84% | -38.71% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 26.81% | -38.68% | |||
| Operating Income | -26.81% | 38.68% | |||
| Income Before Tax | -27.12% | 36.41% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -27.12% | 36.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -27.12% | 36.41% | |||
| EBIT | -26.81% | 38.68% | |||
| EBITDA | -26.84% | 38.71% | |||
| EPS Basic | -26.32% | 36.67% | |||
| Normalized Basic EPS | -25.00% | 36.84% | |||
| EPS Diluted | -26.32% | 36.67% | |||
| Normalized Diluted EPS | -25.00% | 36.84% | |||
| Average Basic Shares Outstanding | -0.04% | 0.41% | |||
| Average Diluted Shares Outstanding | -0.04% | 0.41% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||